The Alzheimer Biomarkers Consortium-Down Syndrome (ABC-DS) is dedicated to advancing our understanding of Alzheimer’s disease in adults with Down syndrome. Through the study of cognitive changes, blood-based proteins, metabolites, genetic markers and brain pathology, the consortium aims to identify early and sensitive indicators of decline. Explore their new website to learn more!
